NCT03786003 ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
| NCT ID | NCT03786003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fudan University |
| Condition | Carcinoma, Non-Small-Cell Lung |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,086 participants |
| Start Date | 2022-02-09 |
| Primary Completion | 2025-02-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,086 participants in total. It began in 2022-02-09 with a primary completion date of 2025-02-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1007). The goal of this study is to determine video-assisted thoracoscopic surgery is non-inferior to thoracotomy in terms of disease-free survival for solid clinical stage T1N0M0 NSCLC.
Eligibility Criteria
Inclusion Criteria: * Clinical stage T1N0M0 and surgical resectable. * Solid appearance on computed tomography scan. * Age 18 to 75 year. * Signed the informed consent form. Exclusion Criteria: * Not NSCLC in pathological analysis. * Not lobectomy or sublobar resection. * History of other malignant tumors within 5 years. * History of thoracic surgery or unsuitable for VATS. * Previous radiation or chemotherapy.
Contact & Investigator
Shanghai Cancer Center Chen, Ph.D
PRINCIPAL INVESTIGATOR
Shanghai Cancer Center
Frequently Asked Questions
Who can join the NCT03786003 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Carcinoma, Non-Small-Cell Lung. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03786003 currently recruiting?
Yes, NCT03786003 is actively recruiting participants. Contact the research team at haoxuanwu@hotmail.com for enrollment information.
Where is the NCT03786003 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT03786003 clinical trial?
NCT03786003 is sponsored by Fudan University. The principal investigator is Shanghai Cancer Center Chen, Ph.D at Shanghai Cancer Center. The trial plans to enroll 1,086 participants.